BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21969365)

  • 1. A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation.
    Wu W; Sun XH
    J Biol Chem; 2011 Dec; 286(48):41153-41162. PubMed ID: 21969365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
    Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
    Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
    Huang Z; Nie L; Xu M; Sun XH
    Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP.
    Nie L; Wu H; Sun XH
    J Biol Chem; 2008 Jan; 283(2):684-92. PubMed ID: 17962192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for the d-Asb11 cul5 Box domain for proper notch signaling and neural cell fate decisions in vivo.
    Sartori da Silva MA; Tee JM; Paridaen J; Brouwers A; Runtuwene V; Zivkovic D; Diks SH; Guardavaccaro D; Peppelenbosch MP
    PLoS One; 2010 Nov; 5(11):e14023. PubMed ID: 21124961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
    Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
    Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
    Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes.
    Kohroki J; Nishiyama T; Nakamura T; Masuho Y
    FEBS Lett; 2005 Dec; 579(30):6796-802. PubMed ID: 16325183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
    Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
    Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Janus kinase 3: the controller and the controlled.
    Wu W; Sun XH
    Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):187-96. PubMed ID: 22130498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECSASB2 mediates MLL degradation during hematopoietic differentiation.
    Wang J; Muntean AG; Hess JL
    Blood; 2012 Feb; 119(5):1151-61. PubMed ID: 22174154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
    Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.
    Heuzé ML; Guibal FC; Banks CA; Conaway JW; Conaway RC; Cayre YE; Benecke A; Lutz PG
    J Biol Chem; 2005 Feb; 280(7):5468-74. PubMed ID: 15590664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
    Chen G; Wang Y; Garate M; Zhou J; Li G
    Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
    Nie L; Xu M; Vladimirova A; Sun XH
    EMBO J; 2003 Nov; 22(21):5780-92. PubMed ID: 14592976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.
    Nishitani H; Sugimoto N; Roukos V; Nakanishi Y; Saijo M; Obuse C; Tsurimoto T; Nakayama KI; Nakayama K; Fujita M; Lygerou Z; Nishimoto T
    EMBO J; 2006 Mar; 25(5):1126-36. PubMed ID: 16482215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.